Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Clinical study determines pharmacokinetics of oral formulation of antibiotic TP-434

May 16, 2011

First-in-class antimicrobial zempia is active against clinical bacterial isolates

May 16, 2011

New antiviral agent OBR-5-340 is active against coxsackievirus B3 and rhinovirus 5

May 13, 2011

First-in-human data reported on FAB Pharma's antibacterial agent MUT-056399

May 13, 2011

Snapshots: Promising preclinical data on ImmunoGen's anticancer agents IMGN-853 and IMGN-529

May 13, 2011

KAG-308 has beneficial effects in models of chronic colitis

May 12, 2011

Preclinical data disclosed on RDX-5791 for constipation

May 12, 2011

PEM antibiotic POL-7080 well tolerated in phase I study

May 12, 2011

Clinical trial tests effect of food, H2R blockade and vitamin C on GSK-1322322 pharmacokinetics

May 12, 2011

Preclinical safety data on FCFD-4514-S enable advancement to clinic for geographic atrophy

May 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...